This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
In vivo bioluminescence imaging of natural bacteria within deep tissues via ATP-binding cassette sugar transporter
Nature Communications Open Access 22 April 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
23 August 2017
In the August 2017 issue, the story “Breaking through: How researchers are gaining entry into barricaded bacteria” (Nat. Med. 23, 907–910, 2017) misstated that the pharmaceutical company Achaogen would be filing a New Drug Application with the FDA in 2018. The company will be filing an Investigational New Drug application. The article was also unclear in wording the progress of siderophore-conjugated antibiotics. Such antibiotics have made it to clinical trials, but none so far have made it to market. The errors have been corrected in the HTML and PDF versions of the article as of 23 August 2017.
Author information
Author notes
Shraddha Chakradhar is Nature Medicine's associate news editor in Boston.
- Shraddha Chakradhar
Rights and permissions
About this article
Cite this article
Chakradhar, S. Breaking through: How researchers are gaining entry into barricaded bacteria. Nat Med 23, 907–910 (2017). https://doi.org/10.1038/nm0817-907
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0817-907
This article is cited by
-
In vivo bioluminescence imaging of natural bacteria within deep tissues via ATP-binding cassette sugar transporter
Nature Communications (2023)
-
Correction
Nature Medicine (2017)